Diversified Healthcare TrustDHC
Recorded

Diversified Healthcare Trust 2026 Q3 Earnings Call

Review the key takeaways and the transcript of this earnings call.

PeriodQ3 2026Duration28 minParticipants6

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Operator

Good morning, and welcome to the Diversified Healthcare Trust Third Quarter 2026 Earnings Conference Call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad. To withdraw your question, please press star then two. Please note, this event is being recorded. I would now like to turn the conference over to Matthew Murphy, Manager of Investor Relations. Please go ahead. Good morning.

Matt MurphyManager of Investor Relations

Joining me on today's call are Chris Bilotto, President and Chief Executive Officer, and Matt Brown, Chief Financial Officer and Treasurer. Today's call includes a presentation by management, followed by a question-and-answer session with sell-side analysts. Please note that the recording and retransmission of today's conference call is strictly prohibited without the prior written consent of the company. Today's conference call contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. These forward-looking statements are based upon DHC's beliefs and expectations as of today, Tuesday, November 3rd, 2026. The company undertakes no obligation to revise or publicly release the results of any revision to the forward-looking statements made in today's conference call, other than through filings with the Securities and Exchange Commission or SEC. Actual results may differ materially from those projected in any forward-looking statements.

Matt MurphyManager of Investor Relations

Additional information concerning factors that could cause those differences is contained in our filings with the SEC. Investors are cautioned not to place undue reliance upon any forward-looking statements. In addition, this call may contain non-GAAP numbers, including normalized funds from operations or Normalized FFO, net operating income or NOI, cash basis net operating income or cash basis NOI, and Adjusted EBITDAre. A reconciliation of these non-GAAP measures to net income is available in our financial results package, which can be found on our website at www.dhcreit.com. Beginning this quarter, our calculations of Normalized FFO and Adjusted EBITDAre include estimated incentive management fees accrued under GAAP, and prior periods have been recast to conform to this presentation. Finally, we will be providing guidance on this call, including NOI.

Matt MurphyManager of Investor Relations

We are not providing a reconciliation of these non-GAAP measures as part of our guidance, because certain information required for such reconciliation is not available without unreasonable efforts or at all, such as gains and losses or impairment charges related to the disposition of real estate. With that, I would now like to turn the call over to Chris.

Chris BilottoPresident and CEO

Thank you, Matt. Good morning, everyone, and thank you for joining our call today. Our third quarter results reflect continued execution on the strategy we have laid out for the year. That strategy shows up across stronger operating results in our SHOP portfolio, active optimization of how we own and operate individual assets, and a steadily improving financial profile. Following the market close yesterday, DHC reported Normalized FFO of $30.7 million, or $0.13 per share, and Adjusted EBITDAre of $73.4 million, an increase of 28.4% year-over-year. Same property cash basis NOI increased 25.6% to $77.9 million, and consolidated NOI increased 27.5% to $80.8 million. Before going further, I want to note a change in our presentation.

Chris BilottoPresident and CEO

Beginning this quarter, Adjusted EBITDAre and Normalized FFO include incentive management fees as recognized under GAAP, and prior periods have been recast on the same basis. On that comparable basis, Normalized FFO increased from $0.12 per share in the second quarter and from $0.02 per share a year ago, and Adjusted EBITDA increased both sequentially and year-over-year. point, and lowering our expected SHOP recurring capital expenditures by $10 million. Matt will walk through the full guidance update, including the effect of the incentive management fee change. Let me start with our SHOP segment. Same property NOI increased 50.4% year-over-year to $48 million. This growth was driven by a 200 basis point increase in occupancy to 84.4%, and a 5.2% increase in average monthly rate, which together expanded same property NOI margin by 470 basis points to 15.8%.

Chris BilottoPresident and CEO

We used targeted move-in incentives this quarter to accelerate occupancy, which kept average monthly rate flat sequentially. As communities stabilize, we expect to reduce these concessions and allow rate growth to flow through more fully. Expense discipline also continues with our dietary procurement initiatives, contributing to an expense reduction by approximately $1.3 million compared with the prior year. Importantly, we believe significant embedded upside remains. With same property occupancy at 84.4%, we estimate 500 to 600 basis points of occupancy upside as our operators close the occupancy gaps between our communities and the respective NIC markets. Beyond occupancy, we continue to reposition underutilized and closed skilled nursing wings into independent living, assisted living, and memory care units. We have now approved projects across 13 communities that we expect will add approximately 356 units.

Chris BilottoPresident and CEO

We expect these investments to generate stabilized cash returns in the mid-teens or better while converting vacant space into revenue-generating units. Finally, we are putting new management agreements in place across 76 SHOP communities that are managed by our legacy operators. Implementation is expected on January 1st, 2027. These agreements extend the operator framework we initiated across our transition communities in 2025, including more closely aligned incentive structures and appropriately sized base management fees. We expect them to initially generate approximately $2 million of annual cost savings while further aligning operator incentives with shareholder interests. Turning to our portfolio optimization strategy. Over the past two years, DHC has repositioned its portfolio through asset sales, operator transitions, and targeted capital investment. With much of that foundation in place, we are increasingly focused on optimizing individual assets.

Chris BilottoPresident and CEO

The clearest example this quarter is our transition of seven skilled nursing facilities in Colorado to a 15-year triple net lease with the Ensign Group, effective on October 1st. This transition does two primary things for us. First, it increases cash flow. First-year contractual rent is approximately $8 million with CPI annual escalators, which compares with $5.1 million of NOI over the prior 12 months, or about $3.5 million after capital expenditures. Second, it sharpens our SHOP portfolio. Skilled nursing relies primarily on government reimbursement and is more labor-intensive, which is why these facilities generated only about a 5.8% margin for the quarter. Skilled nursing is also more commonly under triple net leases with specialized operators.

Chris BilottoPresident and CEO

The new structure shifts reimbursement, labor, and capital exposure to the tenant, leaves our SHOP portfolio more focused on private pay senior housing, and on a pro forma basis, would have lifted our third quarter consolidated SHOP margin by about 80 basis points. We are applying the same asset-by-asset approach to operator alignment. In September, we provided notice to transition 6 SHOP communities in Georgia, representing 486 units, to a new manager, which we expect to begin as early as the fourth quarter. This consolidates these communities with an operator that has deep regional expertise and fits the operator framework we have built across our transition portfolio. We look forward to working closely with them to ensure a seamless transition. Turning to our medical office and life science portfolio. Leasing activity remained healthy during the quarter.

Chris BilottoPresident and CEO

We completed approximately 130,000 sq ft of leasing at rental rates 25% above prior rents, with a weighted average lease term of 9.7 years. As discussed on our second quarter earnings call, two tenants representing approximately 213,000 sq ft vacated on July 1st, and total occupancy declined to 88.4% from 92.2% in the prior quarter. Near-term expirations are limited. Through year-end, $3.3 million of annualized rental income, or 2.1% of the total, is scheduled to expire. This includes $2.2 million from a life science tenant in Fremont, California, that we expect to vacate at the end of November, and we are actively marketing that space for lease. The portfolio's weighted average remaining lease term was approximately 5.1 years at quarter end. As part of our capital recycling efforts, we are actively pursuing disposition opportunities.

Chris BilottoPresident and CEO

As of yesterday, we are under agreement to sell one vacant property consisting of 126,000 sq ft for $10.5 million, and we are evaluating offers on two additional properties totaling approximately 232,000 sq ft. Together, these three properties generated negative NOI of $690,000 during the quarter, or nearly $2.8 million annually. Selling them eliminates that drag and provides capital for reinvestment. Looking ahead, our path to earnings growth is embedded in our existing portfolio. Several drivers are already in motion for 2027: a full year rent from the Ensign lease, approximately $2 million of annual savings from our new SHOP legacy management agreements effective January 1st, skilled nursing NOI conversion projects adding approximately 350 units, and the sale of non-earning medical office properties. Most significant is the continued improvement in SHOP occupancy and rate concessions as rate concessions normalize.

Chris BilottoPresident and CEO

Our third quarter results show this strategy is working with stronger SHOP operations, active optimization of individual assets, an improving financial profile, and a higher SHOP NOI outlook for the year. These results are clearly resonating with investors, as DHC has been the top-performing REIT in the U.S. over the past three years, with a total shareholder return in excess of 277%. We remain confident in our trajectory and in our ability to deliver sustainable earnings growth and long-term value for our shareholders. With that, I'll turn the call over to Matt.

Matt BrownCFO and Treasurer

Thanks, Chris, and good morning, everyone. Before I review our results, I would like to walk through a change to how we present our non-GAAP financial measures. The SEC recently provided its interpretation that incentive management fees accrued under GAAP should be included in normalized FFO and Adjusted EBITDAre. Historically, we excluded the incentive fee in these measures. While we believed our prior approach was appropriate and supported period-to-period comparability, we have adopted the SEC's interpretation and changed our presentation. Beginning this quarter, normalized FFO, Adjusted EBITDAre, and CAD include estimated incentive management fees as they are accrued under GAAP, and we have recast prior periods to conform. To be clear, this is a change in presentation only.

Matt BrownCFO and Treasurer

It does not affect our GAAP results or our cash flows, and it does not change how the incentive fee is calculated or the amount, if any, that would ultimately be payable to RMR. Because the fee is based on DHC's total shareholder return relative to a benchmark index over a three-year period ending December 31st, the accrual will fluctuate from quarter to quarter with our share price. For the third quarter, normalized FFO and Adjusted EBITDAre include $5.4 million, or $0.02 per share, of accrued incentive fees, and year to date, we have accrued $22 million, or $0.09 per share. Page eight of our earnings presentation includes a bridge to previously issued guidance. We believe this bridge will assist our investors with comparability between our revised normalized FFO and Adjusted EBITDAre calculations from prior guidance.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Log in to unlock every statement, the English original, and speaker-by-speaker history.

Log in for the full transcript

Other earnings calls that day

View calls from this day